Home / Recalls / Glaxosmithkline Consumer Healthcare Holdings DBA Haleon / D-0181-2023

D-0181-2023 Class I Terminated

Recalled by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon — Warren, NJ

Recall Details

Product Type: Drugs
Report Date: February 1, 2023
Initiation Date: December 6, 2022
Termination Date: February 26, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 321,246 tablets

Product Description

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

Reason for Recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Distribution Pattern

Nationwide in the USA.

Code Information

a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025